Category Specific RSS

kristy carr

Bubs Australia rebounds in China after CEO fiasco, sees USA growth

Baby formula company Bubs Australia (ASX: BUB) has all but closed the chapter on its financial and legal troubles that…

1 year ago

Bubs goes full steam ahead with US FDA trials in rising market for infant formula

Baby formula and food company Bubs Australia (ASX: BUB) spent a large part of FY23 undertaking reputation management as its…

2 years ago

Bubs presents its rebound plan after bitter breakup with former CEO and Chairman

A bitter boardroom spat has left baby formula company Bubs Australia (ASX: BUB) scrambling to undertake serious damage control following…

2 years ago

Bubs Australia founder and CEO forced out for alleged failure to comply with board directions

Just a month after Bubs Australia (ASX: BUB) announced that executive chairman Dennis Lin would be removed from the business,…

2 years ago

China revenue falls 66% as Bubs reports declining sales

The infant formula market has more than doubled over the past decade. But not all companies have managed to keep…

2 years ago

Bubs lodges letter of intent with FDA to become a permanent seller in the USA

After a successful entry into the USA during their recent dairy crisis, infant nutrition and dairy specialist Bubs Australia (ASX:…

3 years ago